Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 1
2016 1
2017 1
2018 1
2019 3
2020 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 2 Xerostomia, CTCAE"
Page 1
Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K, Lee SH, Cheng Z, Lakshminarayanan P, Peng L, Han P, McNutt TR, Quon H, Lee J. Sheikh K, et al. Radiat Oncol. 2019 Jul 29;14(1):131. doi: 10.1186/s13014-019-1339-4. Radiat Oncol. 2019. PMID: 31358029 Free PMC article.
PURPOSE: To analyze baseline CT/MR-based image features of salivary glands to predict radiation-induced xerostomia 3-months after head-and-neck cancer (HNC) radiotherapy. METHODS: A retrospective analysis was performed on 266 HNC patients who were treated using radi …
PURPOSE: To analyze baseline CT/MR-based image features of salivary glands to predict radiation-induced xerostomia 3-months af …
Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study.
Kiyomi A, Yoshida K, Arai C, Usuki R, Yamazaki K, Hoshino N, Kurokawa A, Imai S, Suzuki N, Toyama A, Sugiura M. Kiyomi A, et al. PLoS One. 2022 Apr 27;17(4):e0267092. doi: 10.1371/journal.pone.0267092. eCollection 2022. PLoS One. 2022. PMID: 35476641 Free PMC article.
The oral care support team determined the OM grade at each sample collection point based on CTCAE version 5.0. ...We compared oral mucosal dryness in pre- and post-index patients with cancer to that in HV (n = 33) using an oral moisture-checking device. Fourteen of …
The oral care support team determined the OM grade at each sample collection point based on CTCAE version 5.0. ...We compared …
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study.
Ballal S, Yadav MP, Satapathy S, Raju S, Tripathi M, Damle NA, Sahoo RK, Bal C. Ballal S, et al. Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3777-3789. doi: 10.1007/s00259-023-06340-y. Epub 2023 Jul 18. Eur J Nucl Med Mol Imaging. 2023. PMID: 37462775
Fatigue was one of the most common treatment-emergent adverse events, with grades 1/2 occurring in 70% of patients and grades 3 or higher in 3.5% of patients. ...Additionally, approximately one-third of patients experienced xerostomia (grades 1/ …
Fatigue was one of the most common treatment-emergent adverse events, with grades 1/2 occurring in 70% of patients and grad …
Radiotherapy for cutaneous head and neck cancer and parotid tumours: a prospective investigation of treatment-related acute swallowing and toxicity patterns.
Moroney LB, Helios J, Ward EC, Crombie J, Burns CL, Yeo SQ, Pelecanos A, Spurgin AL, Blake C, Kenny L, Chua B, Hughes BGM. Moroney LB, et al. Support Care Cancer. 2019 Feb;27(2):573-581. doi: 10.1007/s00520-018-4352-5. Epub 2018 Jul 17. Support Care Cancer. 2019. PMID: 30019149
RESULTS: In both groups, minimal treatment toxicities (grades 0-1) were observed. Xerostomia and dysgeusia were the most frequently reported grade 2 toxicities. ...Symptoms peaked in the final week of treatment and rapidly improved thereafter. A …
RESULTS: In both groups, minimal treatment toxicities (grades 0-1) were observed. Xerostomia and dysgeusia were the mos …
Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
Trada Y, Lee MT, Jameson MG, Chlap P, Keall P, Moses D, Lin P, Fowler A. Trada Y, et al. Radiother Oncol. 2023 Sep;186:109745. doi: 10.1016/j.radonc.2023.109745. Epub 2023 Jun 15. Radiother Oncol. 2023. PMID: 37330056
Absolute and relative change (delta) in SUV(median) were correlated to moderate-severe xerostomia (CTCAE grade 2) at 6 months. Four predictive models were subsequently created using multivariate logistic regression using clinical and radiotherap …
Absolute and relative change (delta) in SUV(median) were correlated to moderate-severe xerostomia (CTCAE grade 2 …
Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
Moroney LB, Helios J, Ward EC, Crombie J, Wockner LF, Burns CL, Spurgin AL, Blake C, Kenny L, Hughes BG. Moroney LB, et al. Oral Oncol. 2017 Jan;64:1-8. doi: 10.1016/j.oraloncology.2016.11.009. Epub 2016 Nov 25. Oral Oncol. 2017. PMID: 28024718
Dysphagia and associated acute toxicities were monitored weekly during treatment and at weeks 2, 4 and 12 post treatment using the CTCAE v4, Functional Oral Intake Score and National Dysphagia Diet Descriptors. RESULTS: 75% experienced Grade 2-3 …
Dysphagia and associated acute toxicities were monitored weekly during treatment and at weeks 2, 4 and 12 post treatment using the …
Ipsilateral irradiation for well lateralized carcinomas of the oral cavity and oropharynx: results on tumor control and xerostomia.
Cerezo L, Martín M, López M, Marín A, Gómez A. Cerezo L, et al. Radiat Oncol. 2009 Sep 1;4:33. doi: 10.1186/1748-717X-4-33. Radiat Oncol. 2009. PMID: 19723329 Free PMC article.
Mean score for dry mouth was 28.1 on the 0-100 QLQ-H&N35 scale. According to CTCAE v3 scale, 87.5% of patients had grade 0-1 and 12.5% grade 2 subjective xerostomia. The unstimulated salivary flow was > 0.2 ml/min in 81.2 …
Mean score for dry mouth was 28.1 on the 0-100 QLQ-H&N35 scale. According to CTCAE v3 scale, 87.5% of patients had grad …
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L, Zhang YW, Hu CS, Guo Y. Kong L, et al. Chin J Cancer. 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518. Chin J Cancer. 2010. PMID: 20426907 Free article. Clinical Trial.
The latest version of the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE 3.0) was used for grading all adverse events. RESULTS: Fifty nine patients were evaluable for treatment response. ...The corresponding rates were 11.9% an …
The latest version of the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE 3.0) was used for …
Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients.
Yadav MP, Ballal S, Sahoo RK, Tripathi M, Seth A, Bal C. Yadav MP, et al. Theranostics. 2020 Jul 23;10(20):9364-9377. doi: 10.7150/thno.48107. eCollection 2020. Theranostics. 2020. PMID: 32802197 Free PMC article.
Molecular tumor response by PERCIST 1 criteria could be conducted in 22/28 (78.6%) patients, which revealed complete response in 2/22 (9%), partial response in 10/22 (45.4%) patients, 2/22 (9%) with stable disease, and 8/22 (36%) with progressive diseases. ...Multiv …
Molecular tumor response by PERCIST 1 criteria could be conducted in 22/28 (78.6%) patients, which revealed complete response in 2/22 …
Two- Versus Four-Times Weekly Acupuncture-Like Transcutaneous Electrical Nerve Stimulation for Treatment of Radiation-Induced Xerostomia: A Pilot Study.
Iovoli AJ, Ostrowski A, Rivers CI, Hermann GM, Groman A, Miller A, Singh AK. Iovoli AJ, et al. J Altern Complement Med. 2020 Apr;26(4):323-328. doi: 10.1089/acm.2019.0131. Epub 2020 Jan 27. J Altern Complement Med. 2020. PMID: 31985266 Free PMC article. Clinical Trial.
Background: Xerostomia occurs in the majority of patients undergoing chemoradiation therapy for head and neck cancer (HNC). ...The purpose of this study was to compare ALTENS treatment by using a four-times weekly schedule for 6 weeks versus a twice-weekly schedule for 12 …
Background: Xerostomia occurs in the majority of patients undergoing chemoradiation therapy for head and neck cancer (HNC). ...The pu …
13 results